Health Canada approves 1st RSV vaccine for older adults, drugmaker says – National | 24CA News
Health Canada has permitted the primary vaccine for respiratory syncytial virus (RSV) for adults aged 60 and over.
Manufacturer GSK says the federal company has permitted its new vaccine known as Arexy.
Doctors have been calling for an RSV vaccine for seniors as a result of though the virus is widespread, older individuals are more likely to change into severely sick and require hospitalization.
RSV season in Canada normally begins within the late fall and lasts till spring.
GSK says a randomized medical trial confirmed the vaccine was 82 per cent efficient at stopping decrease respiratory tract illness brought on by RSV in comparison with seniors who bought a placebo.
The firm says it was 94 per cent efficient at stopping the sickness in seniors with underlying medical situations.
